Healthcare provider profile · identity verified

Matthew Stephen Mciff, MD

Family Practice · ST GEORGE, UT · NPI 1437358280

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	430	132
Losartan Potassium	Losartan Potassium	393	111
Omeprazole	Omeprazole	337	101
Levothyroxine Sodium	Levothyroxine Sodium	265	82
Tamsulosin Hcl	Tamsulosin Hcl	213	63
Metoprolol Succinate	Metoprolol Succinate	209	65
Lisinopril	Lisinopril	207	66
Amlodipine Besylate	Amlodipine Besylate	165	53
Metformin Hcl	Metformin Hcl	160	51
Zolpidem Tartrate	Zolpidem Tartrate	159	24
Gabapentin	Gabapentin	143	39
Pravastatin Sodium	Pravastatin Sodium	143	51
Lorazepam	Lorazepam	141	33
Trazodone Hcl	Trazodone Hcl	140	45
Pantoprazole Sodium	Pantoprazole Sodium	137	39
Hydrochlorothiazide	Hydrochlorothiazide	131	38
Tramadol Hcl	Tramadol Hcl	115	35
Alprazolam	Alprazolam	113	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	109	29
Simvastatin	Simvastatin	109	32
Eliquis	Apixaban	105	32
Furosemide	Furosemide	100	35
Potassium Chloride	Potassium Chloride	100	37
Rosuvastatin Calcium	Rosuvastatin Calcium	94	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	89	21
Trulicity	Dulaglutide	88	17
Fluoxetine Hcl	Fluoxetine Hcl	86	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	85	33
Spironolactone	Spironolactone	85	32
Sertraline Hcl	Sertraline Hcl	79	28
Glipizide	Glipizide	73	22
Albuterol Sulfate Hfa	Albuterol Sulfate	72	25
Donepezil Hcl	Donepezil Hcl	68	23
Glipizide Er	Glipizide	64	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	20
Citalopram Hbr	Citalopram Hydrobromide	59	16
Escitalopram Oxalate	Escitalopram Oxalate	59	16
Clonazepam	Clonazepam	58	suppressed
Alendronate Sodium	Alendronate Sodium	57	19
Allopurinol	Allopurinol	57	15
Fluticasone Propionate	Fluticasone Propionate	56	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	17
Finasteride	Finasteride	53	16
Metoprolol Tartrate	Metoprolol Tartrate	53	17
Cephalexin	Cephalexin	49	30
Carvedilol	Carvedilol	47	14
Temazepam	Temazepam	46	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	45	12
Estradiol	Estradiol	41	21
Ezetimibe	Ezetimibe	41	14
Lovastatin	Lovastatin	41	11
Meloxicam	Meloxicam	40	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Propranolol Hcl	Propranolol Hcl	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	15
Sumatriptan Succinate	Sumatriptan Succinate	39	12
Duloxetine Hcl	Duloxetine Hcl	38	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Prednisone	Prednisone	33	22
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	25
Atenolol	Atenolol	32	12
Metformin Hcl Er	Metformin Hcl	32	suppressed
Synthroid	Levothyroxine Sodium	31	11
Ibuprofen	Ibuprofen	30	11
Pregabalin	Pregabalin	30	suppressed
Baclofen	Baclofen	29	11
Bupropion Xl	Bupropion Hcl	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	16
Xarelto	Rivaroxaban	27	suppressed
Amoxicillin	Amoxicillin	26	25
Famotidine	Famotidine	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Linzess	Linaclotide	26	suppressed
Ozempic	Semaglutide	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Fluconazole	Fluconazole	24	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Ondansetron Odt	Ondansetron	23	15
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Testosterone Cypionate	Testosterone Cypionate	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Azithromycin	Azithromycin	19	18
Carisoprodol	Carisoprodol	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Dutasteride	Dutasteride	18	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Topiramate	Topiramate	12	suppressed
Torsemide	Torsemide	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Modafinil	Modafinil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error